Trial Profile
Comparison of Digoxin and Ivabradine in Heart Failure With Preserved Systolic Function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Digoxin (Primary) ; Ivabradine (Primary)
- Indications Atrial fibrillation; Heart failure
- Focus Therapeutic Use
- Acronyms DIGvsIVA
- 09 Feb 2017 New trial record